Cargando…

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA

Detalles Bibliográficos
Autores principales:	Yalcin, Arzu Didem, Celik, Betul, Kumru, Selahattin, Gumuslu, Saadet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406463/ http://dx.doi.org/10.1186/1939-4551-8-S1-A12

Ejemplares similares

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
por: Yalcin, Ata Nevzat, et al.
Publicado: (2015)

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity
por: Arik, Hasan Onur, et al.
Publicado: (2014)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking
por: Kargi, Aysegul, et al.
Publicado: (2013)

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers
por: Arık, Hasan Onur, et al.
Publicado: (2013)

367 Evaluation of Allergen Sensitivity in Patients with Contact Dermatitis in Antalya
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Improving the low solubility of resveratrol
por: Atanacković, Milica T, et al.
Publicado: (2012)

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone
por: Uzun, Rusen, et al.
Publicado: (2016)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
por: Celik, Betül, et al.
Publicado: (2013)

The generation and function of soluble apoE receptors in the CNS
por: Rebeck, G William, et al.
Publicado: (2006)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1998)

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Local production of soluble CD163 in the spondyloarthropathic joint
por: Baeten, D, et al.
Publicado: (2003)

Identification of new inhibitors of soluble guanylyl cyclase activity
por: Vijayraghavan, Jagamya, et al.
Publicado: (2015)

The discovery and characterization of novel soluble guanylate cyclase stimulators
por: Masferrer, Jaime L
Publicado: (2015)

Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis
por: Laustsen, Julie K, et al.
Publicado: (2014)

Vitamin D serum levels in allergic rhinitis
por: Kose, Sukran, et al.
Publicado: (2015)

There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders
por: Akman-Karakaş, Ayşe, et al.
Publicado: (2013)

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
por: Tai, Leon M, et al.
Publicado: (2014)

Acid-soluble chromatin proteins from liver of genetically immobilized rabbit
por: Palyga, J, et al.
Publicado: (1982)

Nitrosopersulfide (SSNO(-)) targets soluble guanylyl cyclase and induces vasodilation in vivo
por: Cortese-Krott, Miriam M, et al.
Publicado: (2015)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Adhesion molecule, soluble adhesion molecule, and cytokine levels in patients with severe burns
por: Endo, S, et al.
Publicado: (1998)

Elevated levels of soluble intercellular adhesion molecule -1 in systemic lupus erythematosus
por: Kljukvina, N, et al.
Publicado: (2001)

Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum
por: Tarn, JR, et al.
Publicado: (2013)

Soluble osteopontin concentrations in serum and ascites of women with advanced serous ovarian cancer
por: Černe, Katarina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eo0ps7q99l7ehfek2qm2l73b4h